Drreddys Laboratories | RDY - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
ANI Pharmaceuticals USD 4.41M 316K 2025-12
Aurora Cannabis CAD 2.11M 116K 2025-12
Bayer EUR 675M 87M 2025-12
Canopy Growth CAD 7.34M 1.46M 2025-12
Cipla INR 140.3M 8.5M 2025-12
Corcept Therapeutics USD 823.61M 21.88M 2025-09
Drreddys Laboratories INR 944M 127M 2025-12
GlaxoSmithKline GBP 188M 21M 2025-12
Hikma Pharmaceutical USD 67M 47M 2025-12
Lonza CHF 84M 14M 2025-06
Novartis USD 304M 23M 2025-12
Pacira USD 3.89M 387K 2025-12
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 10.67M 636K 2025-12
Richter Gedeon HUF 7.5B 9.53B 2024-09
Sun Pharmaceuticals INR 998.6M 250.6M 2025-09
Supernus Pharmaceuticals USD 910K 278K 2023-06
Teva Pharmaceutical Industries USD 220M 17M 2025-12